Insights from "EVER-Vilda", Expert Perspective on Vildagliptin's Applicability in Indian T2DM Patients
Written By : Dr. Nandita Mohan
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-03-13 21:15 GMT | Update On 2024-05-02 08:42 GMT
Advertisement
The "EVER-Vilda" opinion paper is an Indian expert's evaluation of the efficacy and rationality of vildagliptin. It underscores vildagliptin's versatile applicability, safety and provides practical guidance for healthcare professionals regarding the use of Vildagliptin in T2DM care.
This expert consensus article has been published in the February 2024 issue of the Journal of Clinical Medicine Insights: Endocrinology and Diabetes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.